Rivastigmine (ENA 713 free base) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 µM , 4.15 µM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimers type and dementia due to Parkinsons disease[1][2].
Molecular Weight:
250.34
Purity:
99.93
CAS Number:
[123441-03-2]
Formula:
C14H22N2O2
Target:
Cholinesterase (ChE)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
